TXT
58
-2
EFX
58
14
HCA
42
3
LNC
43
-3
ORCL
58
2
LMT
59
5
PYPL
45
-5
AMGN
41
-6
AON
32
-4
HCP
78
16
CNX
63
-4
C
44
-2
ADM
34
-3
PLD
40
2
FOXA
35
-2
MU
48
2
LUV
40
-5
LYB
36
-10
EL
46
-6
HSY
41
-2
TXT
58
-2
EFX
58
14
HCA
42
3
LNC
43
-3
ORCL
58
2
LMT
59
5
PYPL
45
-5
AMGN
41
-6
AON
32
-4
HCP
78
16
CNX
63
-4
C
44
-2
ADM
34
-3
PLD
40
2
FOXA
35
-2
MU
48
2
LUV
40
-5
LYB
36
-10
EL
46
-6
HSY
41
-2
Financhill
Back

Praxis Precision Medicines 10K Form

Sell
39

PRAX
Praxis Precision Medicines

Last Price:
54.87
Seasonality Move:
-34.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRAX News And Ratings

See the #1 stock for the next 7 days that we like better than PRAX

PRAX Financial Statistics

Sales & Book Value

Annual Sales: $2.45M
Cash Flow: $-23.86M
Price / Cash Flow: 0
Annual Sales: $7.92
Price / Book: 10.05

Profitability

EPS (TTM): -22.59000
Net Income (TTM): $-123.28M
Gross Margin: --
Return on Equity: -153.09%
Return on Assets: -115.6%

Praxis Precision Medicines Earnings Forecast

Key Praxis Precision Medicines Financial Ratios

  • The Research & Development expenses have been 3,545.81% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Praxis Precision Medicines Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRAX
CUSIP: 74006W
Website: praxismedicines.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.39
Quick Ratio: 5.16

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRAX Technical Analysis vs Fundamental Analysis

Sell
39
Praxis Precision Medicines (PRAX) is a Sell

Is Praxis Precision Medicines a Buy or a Sell?